Brief: Accelerate Diagnostics - Entered Into Privately Negotiated Exchange Agreement With Holder Of Co's 2.50% Convertible Senior Notes Due 2023
March 21 (Reuters) - Accelerate Diagnostics Inc AXDX.O :
* ACCELERATE DIAGNOSTICS - ON MARCH 20 ENTERED INTO
PRIVATELY
NEGOTIATED EXCHANGE AGREEMENT WITH HOLDER OF CO'S 2.50%
CONVERTIBLE SENIOR NOTES DUE 2023
* ACCELERATE DIAGNOSTICS - UNDER AGREEMENT, NOTEHOLDER HAS
AGREED
TO EXCHANGE WITH CO $14 MILLION OF NOTES HELD BY IT IN 8 EQUAL
TRANCHES
Source text for Eikon: ID:
Further company coverage: AXDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Accelerate Diagnostics
See all newsBrief: Accelerate Diagnostics Files For Chapter 11 Protection And Agrees To Terms To Sell Substantially All Assets
Brief: Accelerate Diagnostics files for Chapter 11 bankruptcy
Accelerate Diagnostics Inc expected to post a loss of 49 cents a share - Earnings Preview
Accelerate Diagnostics Inc reports results for the quarter ended December 31 - Earnings Summary
Accelerate Diagnostics Inc expected to post a loss of 49 cents a share - Earnings Preview